288 related articles for article (PubMed ID: 19734642)
1. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
3. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
4. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
Abbruzzese JL
JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
[No Abstract] [Full Text] [Related]
6. Pancreatic cancer.
Clin Evid; 2003 Jun; (9):528-33. PubMed ID: 12967377
[No Abstract] [Full Text] [Related]
7. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
8. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
9. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
[TBL] [Abstract][Full Text] [Related]
12. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
Lluís F
Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
[No Abstract] [Full Text] [Related]
14. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.
Davis JL; Pandalai P; Ripley RT; Langan RC; Steinberg SM; Walker M; Toomey MA; Levy E; Avital I
Trials; 2011 May; 12():129. PubMed ID: 21595953
[TBL] [Abstract][Full Text] [Related]
15. A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression.
Li D; Pant S; Ryan DP; Laheru D; Bahary N; Dragovich T; Hosein PJ; Rolfe L; Saif MW; LaValle J; Yu KH; Lowery MA; Allen A; O'Reilly EM
Pancreatology; 2014; 14(5):398-402. PubMed ID: 25278310
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
Saif MW
JOP; 2006 Jul; 7(4):337-48. PubMed ID: 16832131
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Shivnani AT
JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
[No Abstract] [Full Text] [Related]
19. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
20. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Schroeder M; Erlichman C; Steen PD; Foster NR; Moore DF; Rowland KM; Nair S; Tschetter LK; Fitch TR
J Clin Oncol; 2004 Dec; 22(24):4944-50. PubMed ID: 15611509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
